Indoleamine 2,3 dioxygenase and metabolic control of immune responses. - Test2 - elhamkhani - TriplyDB

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

http://www.wikidata.org/entity/Q34308495

about

Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?T Cells and Cancer: How Metabolism Shapes Immunity The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza Targeting the indoleamine 2,3-dioxygenase pathway in cancer Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms Antioxidants, inflammation and cardiovascular disease Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes Trial watch: IDO inhibitors in cancer therapy Does EBV alter the pathogenesis of malaria?Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA Indoleamine 2,3 dioxygenase in intestinal disease Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications New Insights into IDO Biology in Bacterial and Viral Infections.Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy Evasion of host immune defenses by human papillomavirus Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase T cell exclusion, immune privilege, and the tumor microenvironment Hyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROS IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells High-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometry Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.Plasma Tryptophan and the Kynurenine-Tryptophan Ratio are Associated with the Acquisition of Statural Growth Deficits and Oral Vaccine Underperformance in Populations with Environmental Enteropathy.Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy.Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers.The role of placental tryptophan catabolism Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.Tryptophan catabolism and immune activation in primary and chronic HIV infection Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.Human adipose-derived mesenchymal stem cells alleviate obliterative bronchiolitis in a murine model via IDO.Activation of the STING adaptor attenuates experimental autoimmune encephalitis.Human Neural Stem Cell Therapy for Chronic Ischemic Stroke: Charting Progress from Laboratory to Patients.

P2860

Q26741117-7F22946A-14F7-4D64-9654-AEA35BFD58A0 Q26741252-14AC3BBA-65FD-4B09-8013-D35087E362C2 Q26746104-62E19F42-2ACC-4E9B-9FD8-B8F8412DCEB0 Q26766427-68BF0D8E-9ED1-4D84-B527-94C539261BDD Q26772701-53938122-FE80-40B3-81BB-CE1555C82A7E Q26775471-D2320945-FEAB-479B-95FB-245085BE2A04 Q26781849-77DB4A2C-AF87-4FBA-9127-B6F5A6B44F4A Q26783291-B29C6C61-2C4F-4A95-B8A7-765433BC906A Q26797214-55E02B17-C991-408E-A84D-6B1A6751CC14 Q26800052-B4F0CF33-1363-44E1-9E8E-E4A97E396F41 Q26823009-4EA5A804-100D-4C71-B6EF-9BA7B52E44CC Q26991991-90B0C358-A8C4-4385-9B6E-2C357CF2B472 Q27006866-EF85272D-522E-4FF1-861B-C2CABD65A18F Q27022038-45C1A825-06D6-4408-9EC5-0D4CA2C9C35A Q27022855-853A4A3B-5A1A-43DE-8806-635F31D0F320 Q27025063-C4FFEB03-36EA-434F-B43B-9ED9C4BA9E44 Q27026892-F63438D9-2005-4C92-95E0-89BC5B5AEF88 Q27692028-DF86662A-ACC4-4537-8476-7ADA41358C9F Q28068378-1BE5DC0A-DC04-4B46-8353-6C44A8D53187 Q28073631-D260705C-21D9-4D37-8C26-5DA3B73375DE Q28076194-B8765F16-C8F8-4FC4-89DB-869C3AA64E44 Q28082914-83E29B0C-711E-4ADC-A575-14C42BCACA5E Q28115713-FD62DC01-422F-4A4C-BD61-22EEA4565E3C Q28259872-4472A786-420E-4DE5-BCD4-0205A13050EF Q28543509-C7BDBEB8-EC36-44D2-ADC7-C590053D3112 Q28551043-A9B268C9-1137-48BE-B71B-DD6BF3BA664B Q28650315-147A5AEC-A908-4830-945B-8388FD82E10B Q29994669-3A996AEF-8A67-456D-8FA6-38D233CB5650 Q30275599-C73A3535-B3F0-4919-AAE0-4F57D7494F60 Q30276161-2530EC62-9514-4D04-8076-8A86E66B9CBC Q30578330-A770E3BE-CF5D-44F9-AA4D-1574AE58CE4B Q33570163-7714649B-DBF9-4A2E-A348-A08A3E78DE19 Q33585122-8442AFBB-6BD8-4242-855D-008153774A85 Q33657987-208FABF0-BFC3-4B60-A490-3BEE74804CC3 Q33688517-18A7BCA9-7880-4EBC-AF65-1F5023767E5B Q33697163-EB338262-AD3A-4F77-80E5-7DBFCA6DAD37 Q33710719-4365EAE4-F237-4ED6-94A4-4EFF33F2A9C2 Q33805077-7070E2B7-81A6-43EB-A338-41F24CBEEC17 Q33861332-AA988A00-D1E2-45E8-8137-8F3AF14DA7D1 Q33904790-56A04CC5-0C00-4C37-A680-306E72ABAA77

P2860

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

http://www.wikidata.org/entity/Q34308495

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@ast

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@en

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@nl

type

label

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@ast

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@en

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@nl

prefLabel

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@ast

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@en

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@nl

P1433

Q34308495-66783608-647F-453A-A83F-E84C48E9390B

P1476

Q34308495-10282B41-BED1-454E-9541-35389C6A89E1

P2093

Q34308495-C0D8AB5C-2B42-4864-8490-A64D3C1D1F79

Q34308495-C106F727-9FDE-41D4-92D9-5F30BDBAA3ED

P2860

Q34308495-01D2D8F9-EBA9-4061-B519-92AE3BFDC579

Q34308495-037953D9-664D-40FD-8F60-E5E93E0669BA

Q34308495-06FD1C3F-7CB1-4E3B-9742-D039BF3E4284

Q34308495-0C499D7A-F165-4259-9F73-060761ACBEBE

Q34308495-0C4CD31F-D9C0-427B-AA1A-5B5D2F9348D4

Q34308495-1251391F-3B36-4418-83A0-4EA8E4F2C619

Q34308495-156F2B60-840E-4720-931D-4DC8504EF5B7

Q34308495-18C6240D-A434-44B4-AEE2-3C8F9E5C645F

Q34308495-1C48EEE7-5241-4A3D-A518-F02BEC3747E7

Q34308495-1E76CF5D-F11F-45A5-B9D7-4353B6F2E015

P304

Q34308495-74305840-8FDF-4531-8BFE-A73139B670E6

P31

Q34308495-67742AC1-F440-4F4F-BAF9-9E468C69DC66

P356

Q34308495-049C8D6E-D0AA-4CD7-99C5-A7111634E403

P433

Q34308495-A847E782-B8F0-49FD-ADDD-746A31B8E5D3

P478

Q34308495-A291C1C2-C418-4E03-9B9E-68128AD3BC5C

P577

Q34308495-E75C9AF6-9468-4BAF-9C0E-37596D066B5A

P5875

Q34308495-5C738050-F1C7-4DA8-8C9D-F20E655C975A

P698

Q34308495-6E6A1C79-8A0F-467F-9D15-E7DB61653BF7

P932

Q34308495-76B757F1-9F11-4F75-8E21-4FA77250E701

P356

J.IT.2012.10.001

P1433

Trends in Immunology

P1476

Indoleamine 2,3 dioxygenase and metabolic control of immune responses.

@en

P2093

Andrew L Mellor

http://www.w3.org/2001/XMLSchema#string

David H Munn

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

From inflammation to sickness and depression: when the immune system subjugates the brain

Halofuginone inhibits TH17 cell differentiation by activating the amino acid starvation response

Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism

Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock

P304

137-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IT.2012.10.001

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232719632

http://www.w3.org/2001/XMLSchema#string

P698

23103127

http://www.w3.org/2001/XMLSchema#string

P932

3594632

http://www.w3.org/2001/XMLSchema#string